Brain Vascular Microenvironments in Cancer Metastasis.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
04 03 2022
Historique:
received: 23 12 2021
revised: 27 02 2022
accepted: 01 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 3 5 2022
Statut: epublish

Résumé

Primary tumours, particularly from major solid organs, are able to disseminate into the blood and lymphatic system and spread to distant sites. These secondary metastases to other major organs are the most lethal aspect of cancer, accounting for the majority of cancer deaths. The brain is a frequent site of metastasis, and brain metastases are often fatal due to the critical role of the nervous system and the limited options for treatment, including surgery. This creates a need to further understand the complex cell and molecular biology associated with the establishment of brain metastasis, including the changes to the environment of the brain to enable the arrival and growth of tumour cells. Local changes in the vascular network, immune system and stromal components all have the potential to recruit and foster metastatic tumour cells. This review summarises our current understanding of brain vascular microenvironments, fluid circulation and drainage in the context of brain metastases, as well as commenting on current cutting-edge experimental approaches used to investigate changes in vascular environments and alterations in specialised subsets of blood and lymphatic vessel cells during cancer spread to the brain.

Identifiants

pubmed: 35327593
pii: biom12030401
doi: 10.3390/biom12030401
pmc: PMC8945804
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Neuroscientist. 2019 Apr;25(2):155-166
pubmed: 29799313
Cancer Cell. 2012 Feb 14;21(2):181-95
pubmed: 22340592
Semin Cancer Biol. 2011 Apr;21(2):123-30
pubmed: 21147227
NeuroRx. 2005 Jan;2(1):3-14
pubmed: 15717053
J Neurol Sci. 2020 Apr 15;411:116706
pubmed: 32007755
J Neuroimaging. 2018 Mar;28(2):139-149
pubmed: 29280227
Neuro Oncol. 2017 Oct 19;19(11):1511-1521
pubmed: 28444227
Cancer Rep (Hoboken). 2020 Jan 29;:e1236
pubmed: 33372403
Nat Neurosci. 2018 Oct;21(10):1380-1391
pubmed: 30224810
Anat Rec. 1965 Jun;152(2):155-60
pubmed: 4954087
Nat Rev Neurol. 2017 Dec;13(12):755-763
pubmed: 29104289
Nat Commun. 2021 Nov 1;12(1):6278
pubmed: 34725363
Cytokine. 2011 Jul;55(1):90-7
pubmed: 21498085
Nature. 2018 Feb 22;554(7693):475-480
pubmed: 29443965
Nat Rev Cancer. 2017 Aug 24;17(9):557-569
pubmed: 28835719
Surg Neurol Int. 2013 May 02;4(Suppl 4):S265-88
pubmed: 23717798
Nat Med. 2010 Jan;16(1):116-22
pubmed: 20023634
Adv Mater. 2018 Nov;30(46):e1801362
pubmed: 30066406
Nat Rev Dis Primers. 2019 Jan 17;5(1):5
pubmed: 30655533
Trends Immunol. 2015 Oct;36(10):569-577
pubmed: 26431936
Cell. 2020 Feb 20;180(4):764-779.e20
pubmed: 32059779
iScience. 2020 Jun 26;23(6):101178
pubmed: 32480132
Cancer Med. 2018 Oct;7(10):5118-5129
pubmed: 30256540
Sci Signal. 2017 Oct 03;10(499):
pubmed: 28974649
Cell. 2017 Feb 9;168(4):670-691
pubmed: 28187288
Nat Rev Clin Oncol. 2020 May;17(5):279-299
pubmed: 32080373
Cell. 1994 May 20;77(4):491-502
pubmed: 7910522
Neurochem Res. 2015 Dec;40(12):2583-99
pubmed: 25947369
Oncotarget. 2016 May 10;7(19):27094-107
pubmed: 27027347
Nature. 2020 Sep;585(7823):113-118
pubmed: 32814895
Nat Commun. 2013;4:1853
pubmed: 23673638
Sci Immunol. 2019 Jul 12;4(37):
pubmed: 31300479
Cancer Res. 2009 Feb 1;69(3):828-35
pubmed: 19141644
Oncol Rev. 2017 May 09;11(1):321
pubmed: 28584570
Am J Clin Oncol. 2016 Feb;39(1):98-106
pubmed: 26558876
Semin Cancer Biol. 2020 Feb;60:294-301
pubmed: 31711993
Surg Radiol Anat. 2021 Aug;43(8):1311-1318
pubmed: 33635406
Nature. 2020 Jan;577(7792):689-694
pubmed: 31942068
Nat Rev Cancer. 2014 Mar;14(3):159-72
pubmed: 24561443
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):132-147
pubmed: 28341420
Front Cell Dev Biol. 2020 Dec 15;8:591405
pubmed: 33384994
Acta Neuropathol. 2016 Sep;132(3):317-38
pubmed: 27522506
Nat Rev Clin Oncol. 2011 Jun;8(6):344-56
pubmed: 21487419
Nat Biomed Eng. 2018 Dec;2(12):915-929
pubmed: 30906645
Neuroradiology. 2004 Jul;46(7):565-70
pubmed: 15258709
Clin Cancer Res. 2019 Jun 15;25(12):3617-3629
pubmed: 30814110
Cancer Treat Rev. 2003 Dec;29(6):533-40
pubmed: 14585263
Neurosurgery. 2020 Sep 1;87(3):E281-E288
pubmed: 32302389
Int J Cancer. 2021 Mar 15;148(6):1308-1322
pubmed: 32761606
Neuro Oncol. 2021 Jun 1;23(6):932-944
pubmed: 33367832
Cancer Metastasis Rev. 1989 Aug;8(2):98-101
pubmed: 2673568
J Cutan Pathol. 2019 Aug;46(8):570-578
pubmed: 30927294
Cancer Cell. 2017 Mar 13;31(3):326-341
pubmed: 28292436
Biochim Biophys Acta Rev Cancer. 2017 Jan;1867(1):49-57
pubmed: 27939792
NeuroRx. 2005 Jan;2(1):86-98
pubmed: 15717060
Handb Clin Neurol. 2018;149:43-56
pubmed: 29307360
Cell. 2021 Feb 18;184(4):1000-1016.e27
pubmed: 33508229
Arch Neurol. 1964 Jun;10:575-80
pubmed: 14130416
Front Oncol. 2019 Apr 24;9:219
pubmed: 31069166
Arch Neurol. 1988 Jul;45(7):741-4
pubmed: 3390029
Chin Neurosurg J. 2019 Jan 18;5:1
pubmed: 32922901
Nature. 2005 Dec 8;438(7069):820-7
pubmed: 16341007
Stroke. 2001 Dec 1;32(12):2768-73
pubmed: 11739971
F1000Res. 2019 Jul 29;8:
pubmed: 31448079
Surg Radiol Anat. 2021 Aug;43(8):1353-1357
pubmed: 33550472
Handb Clin Neurol. 2018;149:27-42
pubmed: 29307358
Mol Cancer. 2019 Dec 3;18(1):175
pubmed: 31796058
Science. 2020 Jul 17;369(6501):276-282
pubmed: 32675368
Lancet Neurol. 2018 Nov;17(11):1016-1024
pubmed: 30353860
Nature. 2017 Feb 16;542(7641):352-356
pubmed: 28166538
JCI Insight. 2021 Aug 9;6(15):
pubmed: 34228647
AJNR Am J Neuroradiol. 2020 Oct;41(10):1777-1785
pubmed: 32883667
Nat Rev Cancer. 2020 Jan;20(1):26-41
pubmed: 31601988
Cancer Res. 1988 Jun 15;48(12):3478-84
pubmed: 3370643
Cell Res. 2020 Mar;30(3):229-243
pubmed: 32094452
Cancer Res. 2011 Oct 15;71(20):6547-57
pubmed: 21868759
Int J Nanomedicine. 2020 Apr 30;15:2999-3022
pubmed: 32431498
Cancers (Basel). 2012 Feb 22;4(1):218-43
pubmed: 24213237
Dev Cell. 2019 May 6;49(3):409-424.e6
pubmed: 31063757
Chin Clin Oncol. 2015 Jun;4(2):25
pubmed: 26112811
Nature. 2015 Jul 16;523(7560):337-41
pubmed: 26030524
Oncogene. 2008 Feb 21;27(9):1218-30
pubmed: 17724470
Int J Cancer. 2001 Apr 15;92(2):176-80
pubmed: 11291042
Physiol Rev. 2013 Oct;93(4):1847-92
pubmed: 24137023
Cancer J. 2017 Jan/Feb;23(1):68-74
pubmed: 28114258
Nat Cell Biol. 2015 Feb;17(2):183-94
pubmed: 25621950
Nature. 2018 Aug;560(7717):185-191
pubmed: 30046111
Nature. 2009 Jun 18;459(7249):1005-9
pubmed: 19421193
Nat Commun. 2017 Nov 10;8(1):1434
pubmed: 29127332
Handb Clin Neurol. 2017;145:79-114
pubmed: 28987197
Am J Pathol. 1990 Jan;136(1):95-102
pubmed: 2297053
Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2372-7
pubmed: 25169934
Neuro Oncol. 2020 Mar 5;22(3):423-432
pubmed: 31498868
Oncogenesis. 2016 Sep 12;5(9):e259
pubmed: 27617643
Nat Cell Biol. 2019 Nov;21(11):1403-1412
pubmed: 31685984
Cancer. 1996 Apr 15;77(8):1551-5
pubmed: 8608542
Int J Med Sci. 2018 Feb 12;15(4):368-375
pubmed: 29511372
Commun Biol. 2021 Jul 15;4(1):878
pubmed: 34267311
Neoplasia. 2018 Jul;20(7):710-720
pubmed: 29852323
Nat Rev Cancer. 2012 Mar 22;12(4):252-64
pubmed: 22437870
Cell. 2017 Mar 9;168(6):1101-1113.e13
pubmed: 28283064
Fluids Barriers CNS. 2014 May 01;11:10
pubmed: 24817998
Brain Pathol. 2020 Sep;30(5):863-866
pubmed: 32502305
Front Neurol. 2019 Jul 12;10:751
pubmed: 31354615
Mol Ther Methods Clin Dev. 2018 Aug 02;10:189-196
pubmed: 30094294
Med Oncol. 2015 Jan;32(1):400
pubmed: 25433950
Neuropathol Appl Neurobiol. 1988 Jan-Feb;14(1):1-17
pubmed: 3374751
Nature. 2021 May;593(7858):255-260
pubmed: 33911285
Cancer Res. 2009 Oct 1;69(19):7529-37
pubmed: 19773447
Neurosurgery. 2017 Sep 1;81(3):397-415
pubmed: 28486641
JAMA Netw Open. 2020 Sep 1;3(9):e2015444
pubmed: 32902650
J Neuroimmunol. 1996 Jan;64(1):37-43
pubmed: 8598388
Lancet Oncol. 2018 May;19(5):672-681
pubmed: 29602646
Memo. 2018;11(1):14-17
pubmed: 29606977
Aging (Albany NY). 2020 Jan 6;12(1):318-339
pubmed: 31905344
Cell Death Dis. 2021 Jul 20;12(8):721
pubmed: 34285192
Science. 1999 Jun 18;284(5422):1994-8
pubmed: 10373119
Cancer Sci. 2006 May;97(5):341-7
pubmed: 16630129
Nat Rev Cancer. 2018 Jul;18(7):452-464
pubmed: 29643473
Neuron. 2018 Oct 24;100(2):375-388
pubmed: 30359603
Nat Rev Cancer. 2017 May;17(5):302-317
pubmed: 28303905
J Neurooncol. 2017 Dec;135(3):507-512
pubmed: 28819707
J Exp Med. 2015 Jun 29;212(7):991-9
pubmed: 26077718
Blood. 2007 Feb 1;109(3):1010-7
pubmed: 17032920
N Engl J Med. 2018 Aug 23;379(8):722-730
pubmed: 30134131
Dis Model Mech. 2018 Jul 6;11(7):
pubmed: 29784888
Nat Cell Biol. 2015 Jun;17(6):816-26
pubmed: 25985394

Auteurs

Lucas E Tobar (LE)

Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.

Rae H Farnsworth (RH)

Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.

Steven A Stacker (SA)

Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.
Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC 3050, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH